MPM Capital invests in private and public companies across the drug development process with the goal of transforming. See sector focus and contact routes.
MPM Capital invests in private and public companies across the drug development process with the goal of transforming scientific breakthroughs into life-saving medicines. They have 30+ years of biotech investing, 60 FDA-approved drugs, and 120+ M&A and IPO events. The firm builds and supports companies that transform patient outcomes, such as Orna Therapeutics, Aktis Oncology, and Reunion.
This profile is part of the StartupFundraising firm database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find comparable investors.
Investors like MPM Capital · Full investor directory · Investor access · Company funding database